PAROXETINE EVOLUGEN 20 mg, film-coated tablet scored 14 tablets
Active ingredients: Paroxetine hydrochloride, Paroxetine
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet scored14 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- PAROXETINE EVOLUGEN 20 mg, comprimé pelliculé sécable
- Pharmaceutical form
- comprimé pelliculé sécable
- Route of administration
- orale
- Presentation description
- plaquette(s) thermoformée(s) aluminium de 14 comprimé(s)
- Marketing authorisation holder
- EVOLUPHARM
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 1 Apr 2024
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
69188939CIP73742699CIP133400937426992Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| CHLORHYDRATE DE PAROXÉTINE ANHYDREcomprimé | — | SA |
| PAROXÉTINE BASEcomprimé | 20 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.